» Articles » PMID: 30402046

Microvascular Invasion in HCC: The Molecular Imaging Perspective

Overview
Specialty Radiology
Date 2018 Nov 8
PMID 30402046
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma represents the most frequent primary liver tumor; curative options are only surgical resection and liver transplantation. From 1996, Milan Criteria are applied in consideration of patients with cirrhosis and hepatocellular for liver transplantation; nonetheless, more recently, Milan Criteria have been criticized because they appear over conservative. Apart from number and size of lesions and biomarker levels, which already have been associated with poorer prognosis, overall survival and recurrence rates after transplantation are affected also by the presence of vascular invasion. Microvascular invasion suggests a poor prognosis but it is often hard to detect before transplant. Diagnostic imaging and tumor markers may play an important role and become the main tools to define microvascular invasion. In particular, a possible role could be found for computed tomography, magnetic resonance imaging, and positron emission tomography. In this paper, we analyze the possible role of positron emission tomography as a preoperative imaging biomarker capable of predicting microvascular invasion in patients with hepatocellular carcinoma and thus selecting optimal candidates for liver transplantation.

Citing Articles

Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics.

Samridhi , Setia A, Mehata A, Priya V, Pradhan A, Prasanna P Nanotheranostics. 2024; 8(2):127-149.

PMID: 38328614 PMC: 10845253. DOI: 10.7150/ntno.92184.


Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?.

Liu X, Guo Y, Zhao L, Misdraji J, Kapur T, Abrams T Abdom Radiol (NY). 2023; 48(6):1955-1964.

PMID: 36933025 DOI: 10.1007/s00261-023-03876-3.


18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review.

Ghidaglia J, Golse N, Pascale A, Sebagh M, Besson F Front Med (Lausanne). 2022; 9:924824.

PMID: 35872754 PMC: 9300997. DOI: 10.3389/fmed.2022.924824.


Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion.

Feng W, Cao W, Cui C, Pi X Dis Markers. 2022; 2022:4996471.

PMID: 35634437 PMC: 9142283. DOI: 10.1155/2022/4996471.


Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.

Yang Y, Fan W, Gu T, Yu L, Chen H, Lv Y Front Oncol. 2021; 11:756216.

PMID: 34692547 PMC: 8529277. DOI: 10.3389/fonc.2021.756216.


References
1.
Zhu W, Qing X, Yan F, Luo Y, Li Y, Zhou X . Can the Contrast-Enhanced Ultrasound Washout Rate Be Used to Predict Microvascular Invasion in Hepatocellular Carcinoma?. Ultrasound Med Biol. 2017; 43(8):1571-1580. DOI: 10.1016/j.ultrasmedbio.2017.04.003. View

2.
Ahn S, Lee J, Joo I, Lee E, Lee S, Cheon G . Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT. Abdom Imaging. 2014; 40(4):843-51. DOI: 10.1007/s00261-014-0256-0. View

3.
Kornberg A, Schernhammer M, Friess H . F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma. J Clin Transl Hepatol. 2017; 5(3):224-234. PMC: 5606969. DOI: 10.14218/JCTH.2017.00014. View

4.
Coskun M . Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging. Exp Clin Transplant. 2017; 15(Suppl 2):36-44. DOI: 10.6002/ect.TOND16.L10. View

5.
Donswijk M, Hess S, Mulders T, Lam M . [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies. PET Clin. 2015; 9(4):421-41, v-vi. DOI: 10.1016/j.cpet.2014.07.001. View